Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
892K
-
Shares change
-
+214K
-
Total reported value, excl. options
-
$651K
-
Value change
-
+$102K
-
Number of buys
-
3
-
Number of sells
-
-6
-
Price
-
$0.73
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q2 2023
15 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q2 2023.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 892K shares
.
Largest 10 shareholders include Invenomic Capital Management LP (767K shares), GEODE CAPITAL MANAGEMENT, LLC (48.8K shares), VANGUARD GROUP INC (33.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (15.4K shares), Tower Research Capital LLC (TRC) (11K shares), RENAISSANCE TECHNOLOGIES LLC (10.7K shares), 1832 Asset Management L.P. (2.69K shares), OSAIC HOLDINGS, INC. (2.04K shares), WELLS FARGO & COMPANY/MN (1.07K shares), and Aspire Private Capital, LLC (400 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.